ArticleSocial science & medicine (1982)2011
Effect of the Arizona tobacco control program on cigarette consumption and healthcare expenditures.
Article in Social science & medicine (1982), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.
- A systematic review and network meta-analysis of population-level interventions to tackle smoking behaviour.Nature human behaviour · 2024Pooled it
- Mass media interventions for smoking cessation in adults.The Cochrane database of systematic reviews · 2017Pooled it
- Estimating the return on investment of the New York Tobacco Control Programme: a synthetic control study.BMJ open · 2024Article
- Illuminating a Path Forward for Tobacco Nation: Projected Impacts of Recommended Policies on Geographic Disparities.Tobacco use insights · 2023Article
- Article
- Estimating the return on investment of the Bureau of Tobacco Free Florida tobacco control programme from 1999 to 2015.BMJ open · 2021Article
- Twenty-year health and economic impact of reducing cigarette use: Minnesota 1998-2017.Tobacco control · 2020Article
- The 20-year impact of tobacco price and tobacco control expenditure increases in Minnesota, 1998-2017.PloS one · 2020Article
- The Minnesota SimSmoke Tobacco Control Policy Model of Smokeless Tobacco and Cigarette Use.American journal of preventive medicine · 2019Article
- Evaluating Comprehensive State Tobacco Prevention and Control Programs Using an Outcome Indicator Framework.Health promotion practice · 2019Article
- Screening for Lung Cancer Has Limited Effectiveness Globally and Distracts From Much Needed Efforts to Reduce the Critical Worldwide Prevalence of Smoking and Related Morbidity and Mortality.Journal of global oncology · 2018Article
- Estimated Budget Impact of Adopting the Affordable Care Act's Required Smoking Cessation Coverage on United States Healthcare Payers.Advances in therapy · 2017Article
- Smoking Behavior and Healthcare Expenditure in the United States, 1992-2009: Panel Data Estimates.PLoS medicine · 2016Article
- Measuring Exposure Opportunities: Using Exogenous Measures in Assessing Effects of Media Exposure on Smoking Outcomes.Communication methods and measures · 2016Article
- The effect of the California tobacco control program on smoking prevalence, cigarette consumption, and healthcare costs: 1989-2008.PloS one · 2013Article
- Strong tobacco control program requirements and secure funding are not enough: lessons from Florida.American journal of public health · 2012Article
- Effective tobacco control is key to rapid progress in reduction of non-communicable diseases.Lancet (London, England) · 2012Review
- Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades?Tobacco control · 2012Article
- Program, policy, and price interventions for tobacco control: quantifying the return on investment of a state tobacco control program.American journal of public health · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
This research investigates the relationship between per capita tobacco control expenditures, cigarette consumption, and healthcare expenditures in the state of Arizona. Arizona's tobacco control program, which was established in 1994, concentrates on youth uptake of smoking and avoids public policy and commentary on the tobacco industry. We use a cointegrating time series analysis using aggregate data on healthcare and tobacco control expenditures, cigarette consumption and prices and other data. We find there is a strong association between per capita healthcare expenditure and per capita cigarette consumption. In the long run, a marginal increase in annual cigarette consumption of one pack per capita increases per capita healthcare expenditure by $19.5 (SE $5.45) in Arizona. A cumulative increase of $1.00 in the difference between control state and Arizona per capita tobacco control expenditures increases the difference in cigarette consumption by 0.190 (SE 0.0780) packs per capita. Between 1996 and 2004, Arizona's tobacco control program was associated with a cumulative reduction in cigarette consumption of 200 million packs (95% CI 39.0 million packs, 364 million packs) worth $500 million (95% CI: $99 million, $896 million) in pre-tax cigarette sales to the tobacco industry. The cumulative healthcare savings was $2.33 billion (95% CI $0.37 billion, $5.00 billion) and the cumulative reduction in cigarette. Arizona's tobacco control expenditures are associated with reduced cigarette consumption and healthcare expenditures, amounting to about 10 times the cost of the program through 2004. This return on investment, while large, was less than the more aggressive California program, which did not limit its focus to youth and included tobacco industry denomalization messages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.